A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
about
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study Combining mFOLFOX6 Wit ...... l Cancer as First Line Therapy
@en
type
label
A Study Combining mFOLFOX6 Wit ...... l Cancer as First Line Therapy
@en
prefLabel
A Study Combining mFOLFOX6 Wit ...... l Cancer as First Line Therapy
@en
P17
P6153
P1476
A Phase 2, Open Label, Multice ...... orectal Cancer (mCRC) Subjects
@en
P17
P3098
NCT01478594
P4844
P580
2011-12-01T00:00:00Z
P582
2013-09-01T00:00:00Z